Home › Targets › H3 receptor
H3 receptor (1 companies · 10 programs)
Companies with an active program directed at H3 receptor.
- WAKIX — Narcolepsy Approved
- pitolisant — Idiopathic Hypersomnia Phase 3
- WAKIX — Prader-Willi Syndrome Phase 3
- pitolisant — Myotonic Dystrophy Type 1 Phase 2
- pitolisant — Multiple Sclerosis Preclinical
- WAKIX — Excessive Daytime Sleepiness in Narcolepsy Approved
- WAKIX — Cataplexy in Narcolepsy Approved
- WAKIX — Pediatric Excessive Daytime Sleepiness in Narcolepsy Approved
- WAKIX — Pediatric Cataplexy in Narcolepsy Approved
- pitolisant Phase 1
